CASP3 and neoplasm: Moreover, IHC analyses confirmed that combinations of 4A7 and paclitaxel as compared to either agent alone dramatically decreased the expression of Ki67, a classic cell proliferation marker, and increased the number of tumor cells with positive staining for cleaved caspase-3 (Fig. 6E).